Concepedia

C. N. Jambalos

CN

Statistics

Publications

4

Citations

272

H-Index

4

Active since

2002

Affiliations

Stanford University(Current)

Palo Alto University

C. N. Jambalos is an author at Stanford University specializing in medicine, cancer pharmacology, and chemotherapy.

Publications per year

2002–2004

4

Publications

4

Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer

Vivek Mehta, Cheryl Cho, James M. Ford et al. · International Journal of Radiation Oncology*Biology*Physics · 2002 · 132 citations

, , +16

A phase II study of gefitinib in combination with FOLFOX-4 (IFOX) in patients with metastatic colorectal cancer

George A. Fisher, T. Kuo, C. D. Cho et al. · Journal of Clinical Oncology · 2004 · 88 citations

, , +17

A phase II study of gefitinib in combination with FOLFOX-4 (IFOX) in patients with metastatic colorectal cancer

George A. Fisher, T. Kuo, C. D. Cho et al. · Journal of Clinical Oncology · 2004 · 33 citations

, , +17

Phase I and pharmacokinetic study of BMS-188797, a new taxane analog, administered on a weekly schedule in patients with advanced malignancies.

Ranjana H. Advani, George A. Fisher, Bert L. Lum et al. · PubMed · 2003 · 19 citations

, , +16

1–4 of 4